Occudo Quantitative Strategies’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,476
Closed -$173K 614
2025
Q1
$173K Sell
13,476
-2,507
-16% -$40.3K 0.02% 577
2024
Q4
$275K Buy
+15,983
New +$319K 0.05% 479
2023
Q3
Sell
-16,849
Closed -$646K 933
2023
Q2
$646K Sell
16,849
-98,603
-85% -$3.64M 0.07% 468
2023
Q1
$4.73M Buy
+115,452
New +$4.82M 0.43% 46
2021
Q1
Sell
-6,715
Closed -$233K 725
2020
Q4
$233K Buy
+6,715
New +$189K 0.07% 502

Other funds holding ADNT

Occudo Quantitative Strategies's ADNT Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of Adient (ADNT) in Q2 2025, closing a stake of 13,476 shares — an estimated $173K sold.

Occudo Quantitative Strategies first reported a position in ADNT in Q4 2020 and held it in 5 quarters. The position peaked at $4.73M in Q1 2023. 266 funds tracked by Wall St. Rank hold ADNT as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining Adient position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,476 Adient shares in Q2 2025, an estimated $173K.
  • Occudo Quantitative Strategies first reported a position in Adient in Q4 2020 and held it in 5 quarters.
  • Occudo Quantitative Strategies's Adient position peaked at $4.73M in Q1 2023.
  • 266 funds tracked by Wall St. Rank held Adient as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.